Perseus Biomics in the Media
Explore the latest media coverage to see how our technology and partnerships are shaping the future of microbiome science. From advancements in high-resolution microbiome profiling to real-world applications of our technology, these articles highlight our impact on personalized nutrition, biotechnology, and microbiome research.
March, 2025
In an exciting new pre-print, Perseus Biomics, a Belgium-based biotechnology start-up, presents their technology, DynaMAP (Dynamic Microbiome Abundance Profiling), as a solution for the problem of achieving high-resolution microbiome analysis.
‘By imaging a bacterium’s genome structure instead of reading every nucleotide, DynaMAP quickly and easily reveals strain-defining features in complex samples’ explains Arno Bouwens, R&D Director Perseus Biomics
February, 2025
NutraIngredients featured DynaMAP, highlighting its ability to provide precise, strain-level taxonomic classification without the need for DNA amplification or library preparation. The article explores how this approach enhances microbiome research and enables new applications across various industries.
October, 2021
Perseus Biomics was named a 2021 Startup Champion by the European Innovation Council (EIC) as part of the EIC Accelerator program. This initiative awarded €363 million to 65 innovative startups and SMEs across Europe, supporting companies that develop groundbreaking innovations in healthcare, digital technologies, energy, biotechnology, and space.
June, 2021
Professor Jens Gundlach, winner of the 2021 Breakthrough Prize in Fundamental Physics, is known for his work in highly precise measurements that help scientists better understand gravity, explore the properties of dark energy, and investigate possible interactions with dark matter.
June, 2021
ZEISS and microbiome analytics firm Perseus Biomics establish partnership
“The microbiome is a field of strong research interest with the potential to fundamentally change our understanding of living systems. It has substantial implications for medicine, agriculture and other areas. Abundance analysis of the microbiome is one key element of this research and Perseus’ innovative optical technology has the potential to enable it at a new level. The investment is a way of consistently implementing our strategy in the field of Advanced Sensor and Data Solutions,” says Gerrit Schulte, Head of ZEISS Ventures.
Perseus Biomics in the Spotlight: News & Updates
Watch our 2-minute DynaMAP technology video
Meet DynaMAP™ Technology
Get the latest insights into cutting-edge microbiome profiling. Download our Profiling Report and DynaMAP White Paper to see how precision, high sensitivity, and specificity come together to advance microbiome research.
